Nisha Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nisha Patel has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Ara Darzi
Imperial College London, London, UK
3 shared publications - Arun Sivananthan
Institute of Global Health Innovation, Imperial College London, London, UK
3 shared publications - Aravindhan Baheerathan
Department of Neurology, Charing Cross Hospital, Imperial College NHS Healthcare Trust, London, UK
2 shared publications - Aurélien M. Guéroult
St George's Vascular Institute, St George's, University of London, London, UK
2 shared publications - Geiske Zijlstra
Department of Academic Public Health Imperial College London London United Kingdom
2 shared publications - Guy Martin
Department of Surgery and Cancer, Imperial College London, St Mary’s Hospital, London, UK
2 shared publications
Latest Publications
- 3 November 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (11) , e277644
Primary anorectal malignant melanoma: the limits of preoperative staging
- 3 November 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (11) , e277644
Primary anorectal malignant melanoma: the limits of preoperative staging
- 12 June 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e61-e71
Update on management of non-pedunculated colonic neoplasia
Non-pedunculated colonic neoplasia (NPCN) is increasingly encountered due to expanded bowel cancer screening and improvements in high-definition endoscopy. Flat and sessile lesions carry higher risks of incomplete resection, recurrence and submucosal invasion than pedunculated polyps, making accurate optical diagnosis and appropriate technique selection essential for high-quality care. This review synthesises evidence from 2016 to 2026 providing a contemporary practice-focused update for clinicians delivering endoscopic resection services. Advances in optical characterisation, including Narrow-band imaging International Colorectal Endoscopic classification, Japan NBI Expert Team classification and Kudo pit pattern classifications, have improved real-time prediction of histology and invasion depth, supporting decision-making between cold resection, endomucosal resection (EMR), endoscopic submucosal dissection (ESD) and surgical referral. Cold snare polypectomy and cold EMR have become preferred techniques for small and intermediate lesions due to excellent safety profiles and high complete resection rates. For larger lesions (≥20 mm), piecemeal EMR with systematic margin ablation using snare-tip soft coagulation now represents the standard of care, reducing recurrence to below 10%. Emerging techniques such as underwater EMR, cap-assisted EMR and endoscopic full-thickness resection expand therapeutic options for fibrotic or non-lifting lesions. ESD remains crucial for en bloc resection when superficial submucosal invasion is suspected, though its use varies across the UK and international practice due to differences in training pathways and service configuration. Key knowledge gaps remain, including the role of artificial intelligence-assisted optical diagnosis, comparative effectiveness of advanced resection techniques and the need for standardised global training and quality indicators. Continued evolution of service models, training frameworks and quality assurance will be central to delivering safe, effective and equitable NPCN management.
- 12 June 2026
- Published by BMJ in Frontline Gastroenterology
- Vol. 17 (e1) , e61-e71
Update on management of non-pedunculated colonic neoplasia
Non-pedunculated colonic neoplasia (NPCN) is increasingly encountered due to expanded bowel cancer screening and improvements in high-definition endoscopy. Flat and sessile lesions carry higher risks of incomplete resection, recurrence and submucosal invasion than pedunculated polyps, making accurate optical diagnosis and appropriate technique selection essential for high-quality care. This review synthesises evidence from 2016 to 2026 providing a contemporary practice-focused update for clinicians delivering endoscopic resection services. Advances in optical characterisation, including Narrow-band imaging International Colorectal Endoscopic classification, Japan NBI Expert Team classification and Kudo pit pattern classifications, have improved real-time prediction of histology and invasion depth, supporting decision-making between cold resection, endomucosal resection (EMR), endoscopic submucosal dissection (ESD) and surgical referral. Cold snare polypectomy and cold EMR have become preferred techniques for small and intermediate lesions due to excellent safety profiles and high complete resection rates. For larger lesions (≥20 mm), piecemeal EMR with systematic margin ablation using snare-tip soft coagulation now represents the standard of care, reducing recurrence to below 10%. Emerging techniques such as underwater EMR, cap-assisted EMR and endoscopic full-thickness resection expand therapeutic options for fibrotic or non-lifting lesions. ESD remains crucial for en bloc resection when superficial submucosal invasion is suspected, though its use varies across the UK and international practice due to differences in training pathways and service configuration. Key knowledge gaps remain, including the role of artificial intelligence-assisted optical diagnosis, comparative effectiveness of advanced resection techniques and the need for standardised global training and quality indicators. Continued evolution of service models, training frameworks and quality assurance will be central to delivering safe, effective and equitable NPCN management.
- Open Access
- 4 November 2023
- Published by Elsevier in Current Therapeutic Research
- Vol. 99, 100725
Safety and Performance of Narhinel 0.9% Sodium Chloride Monodose and Otrisal 0.74% Sodium Chloride Monodose Nasal Saline Solutions and Nasal Aspirators in Real-World Settings: Postmarket Clinical Follow-up Study Results
- 4 November 2023
- Published by Elsevier in Current Therapeutic Research
- Vol. 99, 100725
Open AccessSafety and Performance of Narhinel 0.9% Sodium Chloride Monodose and Otrisal 0.74% Sodium Chloride Monodose Nasal Saline Solutions and Nasal Aspirators in Real-World Settings: Postmarket Clinical Follow-up Study Results
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1554: EFFECT OF ANTI-TNF THERAPY ON RISK OF PREECLAMPSIA IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1554: EFFECT OF ANTI-TNF THERAPY ON RISK OF PREECLAMPSIA IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Sa1250: ASSESSING VARIATION IN HISTOLOGY IN PATIENTS WITH CELIAC DISEASE: A QUANTITATIVE APPROACH
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Sa1250: ASSESSING VARIATION IN HISTOLOGY IN PATIENTS WITH CELIAC DISEASE: A QUANTITATIVE APPROACH
- Open Access
- 30 May 2022
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 55 (3) , 355-364
Does computer-aided diagnostic endoscopy improve the detection of commonly missed polyps? A meta-analysis
Background/Aims: Colonoscopy is the gold standard diagnostic method for colorectal neoplasia, allowing detection and resection of adenomatous polyps; however, significant proportions of adenomas are missed. Computer-aided detection (CADe) systems in endoscopy are currently available to help identify lesions. Diminutive (≤5 mm) and nonpedunculated polyps are most commonly missed. This meta-analysis aimed to assess whether CADe systems can improve the real-time detection of these commonly missed lesions.Methods: A comprehensive literature search was performed. Randomized controlled trials evaluating CADe systems categorized by morphology and lesion size were included. The mean number of polyps and adenomas per patient was derived. Independent proportions and their differences were calculated using DerSimonian and Laird random-effects modeling.Results: Seven studies, including 2,595 CADe-assisted colonoscopies and 2,622 conventional colonoscopies, were analyzed. CADe-assisted colonoscopy demonstrated an 80% increase in the mean number of diminutive adenomas detected per patient compared with conventional colonoscopy (0.31 vs. 0.17; effect size, 0.13; 95% confidence interval [CI], 0.09–0.18); it also demonstrated a 91.7% increase in the mean number of nonpedunculated adenomas detected per patient (0.32 vs. 0.19; effect size, 0.05; 95% CI, 0.02–0.07).Conclusions: CADe-assisted endoscopy significantly improved the detection of most commonly missed adenomas. Although this method is a potentially exciting technology, limitations still apply to current data, prompting the need for further real-time studies.
- 30 May 2022
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 55 (3) , 355-364
Open AccessDoes computer-aided diagnostic endoscopy improve the detection of commonly missed polyps? A meta-analysis
Background/Aims: Colonoscopy is the gold standard diagnostic method for colorectal neoplasia, allowing detection and resection of adenomatous polyps; however, significant proportions of adenomas are missed. Computer-aided detection (CADe) systems in endoscopy are currently available to help identify lesions. Diminutive (≤5 mm) and nonpedunculated polyps are most commonly missed. This meta-analysis aimed to assess whether CADe systems can improve the real-time detection of these commonly missed lesions.Methods: A comprehensive literature search was performed. Randomized controlled trials evaluating CADe systems categorized by morphology and lesion size were included. The mean number of polyps and adenomas per patient was derived. Independent proportions and their differences were calculated using DerSimonian and Laird random-effects modeling.Results: Seven studies, including 2,595 CADe-assisted colonoscopies and 2,622 conventional colonoscopies, were analyzed. CADe-assisted colonoscopy demonstrated an 80% increase in the mean number of diminutive adenomas detected per patient compared with conventional colonoscopy (0.31 vs. 0.17; effect size, 0.13; 95% confidence interval [CI], 0.09–0.18); it also demonstrated a 91.7% increase in the mean number of nonpedunculated adenomas detected per patient (0.32 vs. 0.19; effect size, 0.05; 95% CI, 0.02–0.07).Conclusions: CADe-assisted endoscopy significantly improved the detection of most commonly missed adenomas. Although this method is a potentially exciting technology, limitations still apply to current data, prompting the need for further real-time studies.
- Open Access
- 17 May 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (5) , e35674
Using Mixed Reality Headsets to Deliver Remote Bedside Teaching During the COVID-19 Pandemic: Feasibility Trial of HoloLens 2
Background: COVID-19 has had a catastrophic impact in terms of human lives lost. Medical education has also been impacted as appropriately stringent infection control policies precluded medical trainees from attending clinical teaching. Lecture-based education has been easily transferred to a digital platform, but bedside teaching has not. Objective: This study aims to assess the feasibility of using a mixed reality (MR) headset to deliver remote bedside teaching. Methods: Two MR sessions were led by senior doctors wearing the HoloLens headset. The trainers selected patients requiring their specialist input. The headset allowed bidirectional audiovisual communication between the trainer and trainee doctors. Trainee doctor conceptions of bedside teaching, impact of the COVID-19 pandemic on bedside teaching, and the MR sessions were evaluated using pre- and postround questionnaires, using Likert scales. Data related to clinician exposure to at-risk patients and use of personal protective equipment (PPE) were collected. Results: Prequestionnaire respondents (n=24) strongly agreed that bedside teaching is key to educating clinicians (median 7, IQR 6-7). Postsession questionnaires showed that, overall, users subjectively agreed the MR session was helpful to their learning (median 6, IQR 5.25-7) and that it was worthwhile (median 6, IQR 5.25-7). Mixed reality versus in-person teaching led to a 79.5% reduction in cumulative clinician exposure time and 83.3% reduction in PPE use. Conclusions: This study is proof of principle that HoloLens can be used effectively to deliver clinical bedside teaching. This novel format confers significant advantages in terms of minimizing exposure of trainees to COVID-19, reducing PPE use, enabling larger attendance, and delivering convenient and accessible real-time clinical training.
- 17 May 2022
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 6 (5) , e35674
Open AccessUsing Mixed Reality Headsets to Deliver Remote Bedside Teaching During the COVID-19 Pandemic: Feasibility Trial of HoloLens 2
Background: COVID-19 has had a catastrophic impact in terms of human lives lost. Medical education has also been impacted as appropriately stringent infection control policies precluded medical trainees from attending clinical teaching. Lecture-based education has been easily transferred to a digital platform, but bedside teaching has not. Objective: This study aims to assess the feasibility of using a mixed reality (MR) headset to deliver remote bedside teaching. Methods: Two MR sessions were led by senior doctors wearing the HoloLens headset. The trainers selected patients requiring their specialist input. The headset allowed bidirectional audiovisual communication between the trainer and trainee doctors. Trainee doctor conceptions of bedside teaching, impact of the COVID-19 pandemic on bedside teaching, and the MR sessions were evaluated using pre- and postround questionnaires, using Likert scales. Data related to clinician exposure to at-risk patients and use of personal protective equipment (PPE) were collected. Results: Prequestionnaire respondents (n=24) strongly agreed that bedside teaching is key to educating clinicians (median 7, IQR 6-7). Postsession questionnaires showed that, overall, users subjectively agreed the MR session was helpful to their learning (median 6, IQR 5.25-7) and that it was worthwhile (median 6, IQR 5.25-7). Mixed reality versus in-person teaching led to a 79.5% reduction in cumulative clinician exposure time and 83.3% reduction in PPE use. Conclusions: This study is proof of principle that HoloLens can be used effectively to deliver clinical bedside teaching. This novel format confers significant advantages in terms of minimizing exposure of trainees to COVID-19, reducing PPE use, enabling larger attendance, and delivering convenient and accessible real-time clinical training.
- Open Access
- 13 December 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Using Mixed Reality Headsets to Deliver Remote Bedside Teaching During the COVID-19 Pandemic: Feasibility Trial of HoloLens 2 (Preprint)
BACKGROUND COVID-19 has had a catastrophic impact in terms of human lives lost. Medical education has also been impacted as appropriately stringent infection control policies precluded medical trainees from attending clinical teaching. Lecture-based education has been easily transferred to a digital platform, but bedside teaching has not. OBJECTIVE This study aims to assess the feasibility of using a mixed reality (MR) headset to deliver remote bedside teaching. METHODS Two MR sessions were led by senior doctors wearing the HoloLens headset. The trainers selected patients requiring their specialist input. The headset allowed bidirectional audiovisual communication between the trainer and trainee doctors. Trainee doctor conceptions of bedside teaching, impact of the COVID-19 pandemic on bedside teaching, and the MR sessions were evaluated using pre- and postround questionnaires, using Likert scales. Data related to clinician exposure to at-risk patients and use of personal protective equipment (PPE) were collected. RESULTS Prequestionnaire respondents (n=24) strongly agreed that bedside teaching is key to educating clinicians (median 7, IQR 6-7). Postsession questionnaires showed that, overall, users subjectively agreed the MR session was helpful to their learning (median 6, IQR 5.25-7) and that it was worthwhile (median 6, IQR 5.25-7). Mixed reality versus in-person teaching led to a 79.5% reduction in cumulative clinician exposure time and 83.3% reduction in PPE use. CONCLUSIONS This study is proof of principle that HoloLens can be used effectively to deliver clinical bedside teaching. This novel format confers significant advantages in terms of minimizing exposure of trainees to COVID-19, reducing PPE use, enabling larger attendance, and delivering convenient and accessible real-time clinical training.
- 13 December 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUsing Mixed Reality Headsets to Deliver Remote Bedside Teaching During the COVID-19 Pandemic: Feasibility Trial of HoloLens 2 (Preprint)
BACKGROUND COVID-19 has had a catastrophic impact in terms of human lives lost. Medical education has also been impacted as appropriately stringent infection control policies precluded medical trainees from attending clinical teaching. Lecture-based education has been easily transferred to a digital platform, but bedside teaching has not. OBJECTIVE This study aims to assess the feasibility of using a mixed reality (MR) headset to deliver remote bedside teaching. METHODS Two MR sessions were led by senior doctors wearing the HoloLens headset. The trainers selected patients requiring their specialist input. The headset allowed bidirectional audiovisual communication between the trainer and trainee doctors. Trainee doctor conceptions of bedside teaching, impact of the COVID-19 pandemic on bedside teaching, and the MR sessions were evaluated using pre- and postround questionnaires, using Likert scales. Data related to clinician exposure to at-risk patients and use of personal protective equipment (PPE) were collected. RESULTS Prequestionnaire respondents (n=24) strongly agreed that bedside teaching is key to educating clinicians (median 7, IQR 6-7). Postsession questionnaires showed that, overall, users subjectively agreed the MR session was helpful to their learning (median 6, IQR 5.25-7) and that it was worthwhile (median 6, IQR 5.25-7). Mixed reality versus in-person teaching led to a 79.5% reduction in cumulative clinician exposure time and 83.3% reduction in PPE use. CONCLUSIONS This study is proof of principle that HoloLens can be used effectively to deliver clinical bedside teaching. This novel format confers significant advantages in terms of minimizing exposure of trainees to COVID-19, reducing PPE use, enabling larger attendance, and delivering convenient and accessible real-time clinical training.
- Open Access
- 15 February 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (7) , 1980-1989
EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
Background and Aims Obesity associated with diabetes mellitus is a significant worldwide problem associated with considerable health care costs. Whilst surgical intervention is effective, it is invasive, costly and associated with complications. This study aims to evaluate the safety and efficacy of the EndoBarrier®, a duodenal-jejunal sleeve bypass as an alternative treatment of diabetes mellitus in obese patients. Materials and Methods This was a multi-centre, non-randomised trial recruiting obese patients with type 2 diabetes from three sites in the UK. Eligible participants had a BMI of 30–50 kg/m2 and HbA1c levels of 7.5–10%. The study comprised a 12-month period with the EndoBarrier® inserted and a 6-month follow-up period after it had been explanted. The primary study outcomes were weight, BMI, HbA1c levels and fasting insulin and glucose levels. Results Forty-five patients were recruited and 31 patients (69%) completed the 12-month study period. Significant reductions in weight (95%CI 0.62–29.38; p < 0.05) and BMI (95%CI 1.1–8.7; p < 0.005) were documented 12 months after device insertion. The mean HbA1c was significantly reduced (95%CI 0.1–1.6; p < 0.05) after the device insertion period and reductions in metabolic parameters (fasting insulin and glucose levels) were also documented during the study. Adverse events were also assessed in all patients, the vast majority of which were reported as mild. Conclusions The EndoBarrier® appears to be a safe and effective treatment strategy in overweight patients with poor glycaemic control despite medical therapy, or in those who are eligible but decline bariatric surgery.
- 15 February 2018
- Published by Springer Nature in Obesity Surgery
- Vol. 28 (7) , 1980-1989
Open AccessEndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes?
Background and Aims Obesity associated with diabetes mellitus is a significant worldwide problem associated with considerable health care costs. Whilst surgical intervention is effective, it is invasive, costly and associated with complications. This study aims to evaluate the safety and efficacy of the EndoBarrier®, a duodenal-jejunal sleeve bypass as an alternative treatment of diabetes mellitus in obese patients. Materials and Methods This was a multi-centre, non-randomised trial recruiting obese patients with type 2 diabetes from three sites in the UK. Eligible participants had a BMI of 30–50 kg/m2 and HbA1c levels of 7.5–10%. The study comprised a 12-month period with the EndoBarrier® inserted and a 6-month follow-up period after it had been explanted. The primary study outcomes were weight, BMI, HbA1c levels and fasting insulin and glucose levels. Results Forty-five patients were recruited and 31 patients (69%) completed the 12-month study period. Significant reductions in weight (95%CI 0.62–29.38; p < 0.05) and BMI (95%CI 1.1–8.7; p < 0.005) were documented 12 months after device insertion. The mean HbA1c was significantly reduced (95%CI 0.1–1.6; p < 0.05) after the device insertion period and reductions in metabolic parameters (fasting insulin and glucose levels) were also documented during the study. Adverse events were also assessed in all patients, the vast majority of which were reported as mild. Conclusions The EndoBarrier® appears to be a safe and effective treatment strategy in overweight patients with poor glycaemic control despite medical therapy, or in those who are eligible but decline bariatric surgery.